Stanford teams with Intermountain to use genomic data to better match patients to clinical trials

A new consortium has been created to progress cancer care through data sharing and increased access to clinical trials. The Oncology Precision Network (OPN) – backed by consortium members Stanford Cancer Institute, Intermountain Healthcare, Providence Health & Services and Syapse – will share aggregated genomic data on cancer to match patients with the trials of most benefit to them. This will help ensure that more cancer patients outside the major cancer centres can be reached. OPN members span 11 states, 79 hospitals and 800 clinics and there will initially be 100,000 data sets in the database including patient history, genetic data, treatments and outcomes. Once up and running, it is hoped the OPN will benefit 50,000 new cancer patients and 200,000 cancer patients each year.

Serving tasty food is what Afsona Restaurant has been doing to its customers

Give it a try and come enjoy what this restaurant has for you